Vibrations to boost the medicinal molecules of roots

Experimental design in three phases with explicit, quantified Go/No-Go criteria, including prior in silico modelling that allows the parametric space to be reduced and non-cytotoxic windows to be identified before costly experiments.

The proposed causal chain is mechanistically coherent and integrated: it explicitly links membrane deformation to the activation of mechanosensitive channels, to Ca2+ influx, to ROS production via RBOHD, to JA-Ile biosynthesis, and then to the activation of MYC2 and triterpenoid biosynthesis genes. This sequence is supported by independent evidence in the literature, notably the link between mechanical compression and JA (Mielke et al., 2020) and the role of PIEZO in root mechanotransduction (Mousavi et al., 2020).

The proposed causal chain is explicit and mechanistically coherent, with measurable intermediate steps (Ca2+, JA-Ile, biosynthetic genes), which renders it falsifiable and testable.

The market for triterpenic saponins (oleanolic acid, calenduloside) is growing, driven by natural cosmetics (global market for botanical actives ~€4.5 bn, CAGR 8–10%) and nutraceuticals. Actors such as BASF, Ashland and Croda are seeking sustainable alternatives to extraction from wild plants.

The concept of 'mechanical elicitation' is genuinely original and stands apart from classical chemical bioelicitation approaches (MeJA, chitosan): it opens a new paradigm for the spatio-temporal control of secondary biosynthesis, with strong intellectual-property potential over vibrational stimulation protocols and the associated bioreactors.